account_num,net_change,tag,tag_depth,cik
2764,-19091000.0,ContractWithCustomerLiabilityCurrent,3,"1614067_ARIDIS PHARMACEUTICALS, INC."
1422,-25000.0,OtherIncome,1,"1614067_ARIDIS PHARMACEUTICALS, INC."
1652,15000.0,FiniteLivedIntangibleAssetsNet,2,"1614067_ARIDIS PHARMACEUTICALS, INC."
2146,500000.0,RestrictedCashNoncurrent,2,"1614067_ARIDIS PHARMACEUTICALS, INC."
2306,500000.0,RestrictedCashAndCashEquivalentsNoncurrent,3,"1614067_ARIDIS PHARMACEUTICALS, INC."
1864,500000.0,RestrictedCashAndInvestmentsNoncurrent,3,"1614067_ARIDIS PHARMACEUTICALS, INC."
2601,-208000.0,NotesAndLoansPayableCurrent,3,"1614067_ARIDIS PHARMACEUTICALS, INC."
2710,-19091000.0,DeferredRevenueCurrent,2,"1614067_ARIDIS PHARMACEUTICALS, INC."
2603,-1082000.0,NoninterestIncome,1,"1614067_ARIDIS PHARMACEUTICALS, INC."
2763,-208000.0,NotesPayableCurrent,2,"1614067_ARIDIS PHARMACEUTICALS, INC."
536,1986000.0,CapitalizedContractCostNetCurrent,3,"1614067_ARIDIS PHARMACEUTICALS, INC."
3279,-737000.0,DeferredRevenueNoncurrent,2,"1614067_ARIDIS PHARMACEUTICALS, INC."
1721,78000.0,CapitalizedContractCostNetNoncurrent,3,"1614067_ARIDIS PHARMACEUTICALS, INC."
3339,-737000.0,ContractWithCustomerLiabilityNoncurrent,3,"1614067_ARIDIS PHARMACEUTICALS, INC."
229,1000000.0,AccountsReceivableNetCurrent,3,"1614067_ARIDIS PHARMACEUTICALS, INC."
207,1000000.0,AccountsNotesAndLoansReceivableNetCurrent,4,"1614067_ARIDIS PHARMACEUTICALS, INC."
320,1000000.0,ReceivablesNetCurrent,3,"1614067_ARIDIS PHARMACEUTICALS, INC."
868,6566000.0,AssetsCurrent,2,"1614067_ARIDIS PHARMACEUTICALS, INC."
1634,1302000.0,OperatingLeaseRightOfUseAsset,2,"1614067_ARIDIS PHARMACEUTICALS, INC."
1368,645000.0,PropertyPlantAndEquipmentNet,4,"1614067_ARIDIS PHARMACEUTICALS, INC."
1732,15000.0,IntangibleAssetsNetExcludingGoodwill,2,"1614067_ARIDIS PHARMACEUTICALS, INC."
1827,15000.0,IntangibleAssetsNetIncludingGoodwill,2,"1614067_ARIDIS PHARMACEUTICALS, INC."
2041,328000.0,OtherAssetsNoncurrent,2,"1614067_ARIDIS PHARMACEUTICALS, INC."
2091,2868000.0,AssetsNoncurrent,2,"1614067_ARIDIS PHARMACEUTICALS, INC."
2089,9434000.0,Assets,1,"1614067_ARIDIS PHARMACEUTICALS, INC."
2398,-4119000.0,AccountsPayableCurrent,2,"1614067_ARIDIS PHARMACEUTICALS, INC."
2347,-13527000.0,AccountsPayableAndAccruedLiabilitiesCurrent,3,"1614067_ARIDIS PHARMACEUTICALS, INC."
1071,183000.0,RestrictedCashAndInvestmentsCurrent,3,"1614067_ARIDIS PHARMACEUTICALS, INC."
1549,183000.0,RestrictedCashAndCashEquivalentsAtCarryingValue,3,"1614067_ARIDIS PHARMACEUTICALS, INC."
577,1320000.0,CashCashEquivalentsAndShortTermInvestments,4,"1614067_ARIDIS PHARMACEUTICALS, INC."
645,1320000.0,CashAndCashEquivalentsAtCarryingValue,3,"1614067_ARIDIS PHARMACEUTICALS, INC."
1079,183000.0,RestrictedCashCurrent,2,"1614067_ARIDIS PHARMACEUTICALS, INC."
173,-25000.0,Revenues,1,"1614067_ARIDIS PHARMACEUTICALS, INC."
3917,-9434000.0,LiabilitiesAndStockholdersEquity,2,"1614067_ARIDIS PHARMACEUTICALS, INC."
3260,-27882000.0,StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest,2,"1614067_ARIDIS PHARMACEUTICALS, INC."
3316,-27882000.0,StockholdersEquity,1,"1614067_ARIDIS PHARMACEUTICALS, INC."
3834,-202482000.0,RetainedEarningsAccumulatedDeficit,1,"1614067_ARIDIS PHARMACEUTICALS, INC."
3750,-168684000.0,AdditionalPaidInCapital,1,"1614067_ARIDIS PHARMACEUTICALS, INC."
3661,-4000.0,CommonStockValue,3,"1614067_ARIDIS PHARMACEUTICALS, INC."
3465,-37316000.0,Liabilities,1,"1614067_ARIDIS PHARMACEUTICALS, INC."
3645,-1885000.0,LiabilitiesNoncurrent,2,"1614067_ARIDIS PHARMACEUTICALS, INC."
3796,-1885000.0,LiabilitiesOtherThanLongtermDebtNoncurrent,3,"1614067_ARIDIS PHARMACEUTICALS, INC."
3379,-1148000.0,OperatingLeaseLiabilityNoncurrent,3,"1614067_ARIDIS PHARMACEUTICALS, INC."
3154,-35431000.0,LiabilitiesCurrent,2,"1614067_ARIDIS PHARMACEUTICALS, INC."
3017,-15000.0,OtherLiabilitiesCurrent,2,"1614067_ARIDIS PHARMACEUTICALS, INC."
2638,-208000.0,DebtCurrent,2,"1614067_ARIDIS PHARMACEUTICALS, INC."
2737,-208000.0,LongTermDebtAndCapitalLeaseObligationsCurrent,3,"1614067_ARIDIS PHARMACEUTICALS, INC."
110,-1082000.0,RevenueFromContractWithCustomerExcludingAssessedTax,2,"1614067_ARIDIS PHARMACEUTICALS, INC."
1820,-6263000.0,IncomeLossFromContinuingOperationsIncludingPortionAttributableToNoncontrollingInterest,3,"1614067_ARIDIS PHARMACEUTICALS, INC."
232,-25000.0,GrossProfit,1,"1614067_ARIDIS PHARMACEUTICALS, INC."
581,5531000.0,OperatingCostsAndExpenses,2,"1614067_ARIDIS PHARMACEUTICALS, INC."
491,5531000.0,ResearchAndDevelopmentExpense,2,"1614067_ARIDIS PHARMACEUTICALS, INC."
3809,-5912000.0,AccumulatedOtherComprehensiveIncomeLossNetOfTax,2,"1614067_ARIDIS PHARMACEUTICALS, INC."
2257,-6263000.0,IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest,2,"1614067_ARIDIS PHARMACEUTICALS, INC."
2149,-6263000.0,IncomeLossFromContinuingOperationsBeforeIncomeTaxesMinorityInterestAndIncomeLossFromEquityMethodInvestments,3,"1614067_ARIDIS PHARMACEUTICALS, INC."
1264,-6263000.0,OperatingIncomeLoss,1,"1614067_ARIDIS PHARMACEUTICALS, INC."
1112,7345000.0,OperatingExpenses,1,"1614067_ARIDIS PHARMACEUTICALS, INC."
601,1814000.0,SellingGeneralAndAdministrativeExpense,3,"1614067_ARIDIS PHARMACEUTICALS, INC."
597,1814000.0,GeneralAndAdministrativeExpense,2,"1614067_ARIDIS PHARMACEUTICALS, INC."
1912,-6816000.0,NetIncomeLoss,1,"1614067_ARIDIS PHARMACEUTICALS, INC."
2590,-6816000.0,NetIncomeLossAvailableToCommonStockholdersBasic,2,"1614067_ARIDIS PHARMACEUTICALS, INC."
2903,-6816000.0,NetIncomeLossAvailableToCommonStockholdersDiluted,2,"1614067_ARIDIS PHARMACEUTICALS, INC."
2716,-208000.0,LongTermDebtCurrent,2,"1614067_ARIDIS PHARMACEUTICALS, INC."
2552,-9408000.0,AccruedLiabilitiesCurrent,2,"1614067_ARIDIS PHARMACEUTICALS, INC."
1077,-6263000.0,ProfitLoss,2,"1614067_ARIDIS PHARMACEUTICALS, INC."
